COVID-19: A new barrier to treatment for opioid use disorder in the emergency department.  Grunvald W, Herrington R, King R, Lamberson M, Mackey S, Maruti S, Rawson R, Wolfson D.  J Am Coll Emerg Physicians Open. 2021 Mar 17;2(2):e12403…

A glass half empty or a glass half full? Addressing the opioid crisis through the lens of COVID-19 Strathdee SA.  Drug Alcohol Depend. 2021;108680. doi:10.1016/j.drugalcdep.2021.108680, [published online ahead of print, 2021 Mar 18].&nbs…

The Impact of COVID-19 on Access to HIV Prevention Services Among Opioid-Dependent Individuals.  Mistler CB, Curley CM, Rosen AO, El-Krab R, Wickersham JA, Copenhaver MM, Khati A, Shrestha R.  J Community Health. 2021 Mar 26:1–7. doi: 10…

Integrated substance use and prenatal care delivery in the era of COVID-19.  Patton EW, Saia K, Stein MD.  J Subst Abuse Treat. 2021 May;124:108273. doi: 10.1016/j.jsat.2020.108273. Epub 2021 Jan 2. PMID: 33771277; PMCID: PMC7979279. ht…

Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study. Hunter SB, Dopp AR, Ober AJ, Uscher-Pines L.  J Subst Abuse Treat. 2021 May;124:108288. doi: 10.1016/j.jsat.20…

Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial.  Watson DP, Swartz JA, Robison-Taylor L, Mackesy-Amiti ME, Erwin K, Gastala N, Jimenez AD, Staton MD, Messm…